This may suggest that the increased ATP13A2 observed may be associated with the prevalent tau pathology observed in Alzheimer’s disease, as we found no evidence for an association with β-amyloid deposition. This evidence concerns the gene ATP13A2 and early-onset autosomal dominant Alzheimer disease.